Skip Navigation Links.

Fresenius Kabi Oncology Ltd


BSE: 532545 | NSE: FKONCO | ISIN: INE575G01010 
Market Cap: [Rs.Cr.] 1,962 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Multinational

 Discuss this stock
120.90-3.15 [2.5]%
121.05-2.80 [2.3]%
BSE Jun 19,12:55
Day's High | Low 123.95 | 118.00
Day's Volumes 5,088
52Wk High | Low 152.45 | 78.50
Open Price 122.00
Turnover 1,804,380.00
Deliverable Vol. 14,339
6 Mth. Avg. Vol. 37,763.99
NSE Jun 19,12:42
Day's High | Low 123.90 | 118.20
Day's Volumes 76,727
52Wk High | Low 152.60 | 78.30
Open Price 123.00
Turnover 7,736,313.65
Deliverable Vol. 52,617
6 Mth. Avg. Vol. 83,328.83

Jun 19,2013 Open LTP Day's Range Volume
  123.00 121.05 123.90 - 118.20 76,727

Graph: Today |   1w |   1m |   3m |   6m |   1y |   3y Technical Charting  
IndiaInfoline
Make opportunities on the move…get daily stocks tips on your mobile.
Click here for details OR just SMS TIPS to 567675555

Key ratios

  Mar-12 Mar-11 Mar-10
P/E (x) 47.17 28.70 24.29
P/BV (x) 4.05 2.61 3.96
RONW (%) 3.5 9.5 14.9
ROCE (%) 5.4 10.6 12.8
EV/ EVBIDTA (x) 22.38 16.45 18.49
Dividend Yield (%) 0.0 0.0 0.0
APATM(%) 3.6 11.6 16.0
EPS 3.2 3.1 5.1

Shareholding Pattern

Particulars No. of
Shares(Mn) 		% Holdings
Total Promoter Holdings 128.16 81.0
Total Govt Holding (Promoter + Non Promoter) 0.00 0.0
Total Domestic Institutions (Banks/ FI + MF / UTI) 0.41 0.3
Total Foreign Holdings (FII+NRI holdings) 15.09 9.5
Total Non Promoter Corporate Holdings 3.45 2.2
Total Public & Others (Individuals + HUF + Clearing members) 11.11 7.1
Total 158.23 100
View detailed shareholding pattern next

Peer Comparison

Company Market Cap
(Rs. in Cr.) 		P/E (TTM)
(x) 		P/BV (TTM)
(x) 		EV/EBIDTA
(x) 		ROE
(%) 		ROCE
(%) 		D/E
(x)
Glaxosmit Pharma 20,569.82 31.08 10.23 18.86 34.3 45.2 0.00
Sanofi India 5,670.68 31.35 4.75 13.73 15.4 22.5 0.00
Pfizer 3,232.12 15.69 1.89 9.41 15.0 22.1 0.00
Abbott India 2,983.93 17.97 4.61 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 1,962.47 22.97 2.92 22.38 3.5 5.4 0.42
Astrazeneca Phar 1,841.38 0.00 18.46 140.28 10.7 15.2 0.03
Wyeth 1,768.30 13.60 3.08 7.61 33.4 45.1 0.01
Novartis India 1,602.47 13.38 1.78 10.43 20.0 28.8 0.00
Merck 1,070.87 13.39 2.21 7.04 17.5 25.5 0.00
Fulford (India) 234.00 0.00 1.62 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Rakesh Bhargava , Chairman  

Dilip G Shah , Director  

Gerrit Steen , Director  

Michael Schonhofen , Director  

Company Head Office / Quarters:
B-310 Som Datt Chambers-I,
Bhikaji Cama Place,
New Delhi,
New Delhi-110066
Phone : 91-11-26105570
Fax : 91-11-26195965
E-mail : complianceofficer.india@fresenius-kabi.com
Web : http://www.fresenius-kabi-oncology.com
Registrars:
MCS Ltd
F-65 1st Floor
Okhla Industrial Are
Phase-I
New Delhi-110020

Fund Holding

 
Scheme Name No. of Shares
Goldman Sachs CNX 500 Fund (G) 712

Calendar

Jun-2013
M T W T F S S
17 18 19 20 21 22 23
IPO
listNo IPO today
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Foreign Buying Japan Stocks (Yen)
Results
list Coromandel Inter